BRIEF published on 06/10/2025 at 10:11, 11 months 2 days ago Edison Releases Report on BB Biotech Amidst Sector Challenges Investment Strategies Market Volatility Biotech Sector BB Biotech Long-term Outlook
PRESS RELEASE published on 06/10/2025 at 10:06, 11 months 2 days ago Edison issues report on BB Biotech (BION) Edison issues report on BB Biotech (BION) covering the recent challenges and opportunities in the biotech sector, including market volatility and long-term outlook Edison Market Volatility Biotech Sector BB Biotech Long-term Outlook
BRIEF published on 04/25/2025 at 07:05, 1 year ago BB Biotech AG annonce une perte nette de 241 millions de francs suisses au premier trimestre 2025 Perte Nette Portefeuille D'investissement Développement De Médicaments BB Biotech Rapport Intermédiaire
BRIEF published on 04/25/2025 at 07:05, 1 year ago BB Biotech AG Reports CHF 241 Million Net Loss for Q1 2025 Drug Development Net Loss Investment Portfolio Interim Report BB Biotech
BRIEF published on 04/25/2025 at 07:05, 1 year ago BB Biotech Q1 2025: Portfolio Adjustments Amid Volatile Market Market Volatility Investment Portfolio Biotech Sector BB Biotech FDA Approvals
BRIEF published on 04/25/2025 at 07:05, 1 year ago BB Biotech T1 2025 : ajustements de portefeuille dans un contexte de marché volatil Volatilité Du Marché Portefeuille D'investissement BB Biotech Secteur Biotechnologique Approbations De La FDA
PRESS RELEASE published on 04/25/2025 at 07:00, 1 year ago EQS-Adhoc: BB Biotech AG publishes its interim report BB Biotech AG publishes its interim report covering the first three months of 2025 revealing a net loss of CHF 241 mn. More information at report.bbbiotech.ch/Q125 Financial Results Investment Company BB Biotech AG Interim Report Business Activities
PRESS RELEASE published on 04/25/2025 at 07:00, 1 year ago BB Biotech Q1 2025: Sharpened portfolio focus amid continued market volatility BB Biotech AG reports net loss in Q1 2025 due to market volatility. Portfolio focus on innovative biotech companies above USD 1 bn. Details on exits and regulatory milestones Market Volatility BB Biotech AG Biotech Companies Q1 2025 Portfolio Focus
BRIEF published on 03/19/2025 at 17:50, 1 year 1 month ago BB Biotech AG Shareholders Approve Dividend and Re-Elect Board Investment Strategy Dividend Board Re-election BB Biotech AGM 2025
BRIEF published on 03/19/2025 at 17:50, 1 year 1 month ago Les actionnaires de BB Biotech AG approuvent le dividende et réélisent le conseil d'administration Dividende Stratégie D'investissement Réélection Du Conseil D'administration BB Biotech Assemblée Générale Annuelle 2025
Published on 05/13/2026 at 08:05, 11 minutes ago Tocvan Announces New Surface Gold-Silver Results, Outlining New Target 3 Kilometers East of Main Zone at Gran Pilar Gold-Silver Project
Published on 05/13/2026 at 00:00, 8 hours 16 minutes ago Onco-Innovations Announces Initiation of Research Collaboration within PROmAI
Published on 05/12/2026 at 23:35, 8 hours 41 minutes ago Infield Minerals Closes $1.25 Million Financing
Published on 05/12/2026 at 21:55, 10 hours 21 minutes ago UraniumX Discovery Corp Announces Option Agreement with Gold'n Futures
Published on 05/13/2026 at 08:05, 11 minutes ago BLUETTI Launches Smart Integrated Balcony Solar Solutions in Paris
Published on 05/13/2026 at 08:00, 16 minutes ago JOST delivers record quarter in Q1 2026: JOST boosts revenue and earnings achieving its strategic profitability target range
Published on 05/13/2026 at 08:00, 16 minutes ago CANCOM SE: CANCOM significantly increases operating profitability in Q1.26
Published on 05/13/2026 at 06:55, 1 hour 21 minutes ago Recticel Group realiseert doorbraak in PIR circulariteit met gerecycleerde polyol
Published on 05/13/2026 at 06:55, 1 hour 21 minutes ago Recticel Group closes the loop on PIR circularity with industrial scale recycled polyol plant
Published on 05/12/2026 at 18:15, 14 hours 1 minute ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 30/04/2026
Published on 05/12/2026 at 18:15, 14 hours 1 minute ago AXA: Information relating to the number of voting rights and shares making up the share capital on 30/04/2026
Published on 05/12/2026 at 18:10, 14 hours 6 minutes ago imerys-12-05-2026-communiqué-compte-rendu-de-l-assemblée-générale-ordinaire-du-12-mai-2026
